Skip to main content
NCBI home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1984 Jun;56(3):614–620.

Heterogeneity, polypeptide chain composition and antigenic reactivity of autoantibodies (F-42) that are directed against the classical pathway C3 convertase of complement and isolated from sera of patients with systemic lupus erythematosus.

M R Daha, H M Hazevoet, L A van Es
PMCID: PMC1535982  PMID: 6430610

Abstract

F-42, an autoantibody found in the sera of some patients with systemic lupus erythematosus, was isolated from sera of seven different patients. By binding of the autoantibodies to cell bound C42, the autoantibodies were purified to homogeneity and radiolabelled with 125I. Purified preparations of 125I-F-42 were bound for at least 96% by 10(9) erythrocytes bearing C4bhuC2hu. Analysis of all 125I-F-42 preparations by SDS-PAGE demonstrated apparent mol. wts of approximately 150,000. After reduction in the presence of 8 M urea each 125I-F-42 preparation yielded heavy and light chains. The heavy chains in some instances were slightly heavier than the heavy chain of normal human IgG. The reaction of 125I-F-42 from the seven patients was positive with Sepharose bound antisera to IgG, kappa, lambda, gamma 1, gamma 2, gamma 3 and in one case to gamma 4. These studies indicate that F-42 is an autoantibody directed against antigens expressed by the classical C3 convertase, C42.

Full text

PDF
614

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arakawa M., Seino J., Kinoshita Y., Fukuda K., Saito T., Furuyama T. Nephritic factor (NeF) of alternate pathway (NeFA) and of classical pathway (NeFc). Tohoku J Exp Med. 1982 Dec;138(4):401–409. doi: 10.1620/tjem.138.401. [DOI] [PubMed] [Google Scholar]
  2. Daha M. R., Austen K. F., Fearon D. T. Heterogeneity, polypeptide chain composition and antigenic reactivity of C3 nephritic factor. J Immunol. 1978 Apr;120(4):1389–1394. [PubMed] [Google Scholar]
  3. Daha M. R., Hazevoet H. M., Hermans J., van Es L. A., Cats A. Relative importance of C4 binding protein in the modulation of the classical pathway C3 convertase in patients with systemic lupus erythematosus. Clin Exp Immunol. 1983 Oct;54(1):248–252. [PMC free article] [PubMed] [Google Scholar]
  4. Daha M. R., Hazevoet H. M., Vanes L. A., Cats A. Stabilization of the classical pathway C3 convertase C42, by a factor F-42, isolated from serum of patients with systemic lupus erythematosus. Immunology. 1980 Jul;40(3):417–424. [PMC free article] [PubMed] [Google Scholar]
  5. Daha M. R., Hazevoet H. M., Vanes L. A. Regulation of immune complex-mediated complement activation by autoantibodies (F-42) isolated from sera of patients with systemic lupus erythematosus. Clin Exp Immunol. 1983 Sep;53(3):541–546. [PMC free article] [PubMed] [Google Scholar]
  6. Daha M. R., Van Es L. A. Stabilization of homologous and heterologous cell-bound amplification convertases, C3bBb, by C3 nephritic factor. Immunology. 1981 May;43(1):33–38. [PMC free article] [PubMed] [Google Scholar]
  7. Daha M. R., van Es L. A. Activation of the classical pathway of complement by the C3NeF-stabilized cell-bound amplification convertase. J Immunol. 1979 Mar;122(3):801–805. [PubMed] [Google Scholar]
  8. Daha M. R., van Es L. A. Relative resistance of the F-42-stabilized classical pathway C3 convertase to inactivation by C4-binding protein. J Immunol. 1980 Nov;125(5):2051–2054. [PubMed] [Google Scholar]
  9. Doekes G., Vanes L. A., Daha M. R. Influence of aggregate size on the binding and activation of the first component of human complement by soluble IgG aggregates. Immunology. 1982 Apr;45(4):705–713. [PMC free article] [PubMed] [Google Scholar]
  10. Gigli I., Fujita T., Nussenzweig V. Modulation of the classical pathway C3 convertase by plasma proteins C4 binding protein and C3b inactivator. Proc Natl Acad Sci U S A. 1979 Dec;76(12):6596–6600. doi: 10.1073/pnas.76.12.6596. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Halbwachs L., Leveillé M., Lesavre P., Wattel S., Leibowitch J. Nephritic factor of the classical pathway of complement: immunoglobulin G autoantibody directed against the classical pathway C3 convetase enzyme. J Clin Invest. 1980 Jun;65(6):1249–1256. doi: 10.1172/JCI109787. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Kijlstra A., van Es L. A., Daha M. R. The role of complement in the binding and degradation of immunoglobulin aggregates by macrophages. J Immunol. 1979 Dec;123(6):2488–2493. [PubMed] [Google Scholar]
  13. LEPOW I. H., NAFF G. B., TODD E. W., PENSKY J., HINZ C. F. Chromatographic resolution of the first component of human complement into three activities. J Exp Med. 1963 Jun 1;117:983–1008. doi: 10.1084/jem.117.6.983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Lewis E. J., Carpenter C. B., Schur P. H. Serum complement component levels in human glomerulonephritis. Ann Intern Med. 1971 Oct;75(4):555–560. doi: 10.7326/0003-4819-75-4-555. [DOI] [PubMed] [Google Scholar]
  15. March S. C., Parikh I., Cuatrecasas P. A simplified method for cyanogen bromide activation of agarose for affinity chromatography. Anal Biochem. 1974 Jul;60(1):149–152. doi: 10.1016/0003-2697(74)90139-0. [DOI] [PubMed] [Google Scholar]
  16. Müller-Eberhard H. J. Complement. Annu Rev Biochem. 1975;44:697–724. doi: 10.1146/annurev.bi.44.070175.003405. [DOI] [PubMed] [Google Scholar]
  17. Nagasawa S., Stroud R. M. Cleavage of C2 by C1s into the antigenically distinct fragments C2a and C2b: demonstration of binding of C2b to C4b. Proc Natl Acad Sci U S A. 1977 Jul;74(7):2998–3001. doi: 10.1073/pnas.74.7.2998. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Parkes C., Gagnon J., Kerr M. A. The reaction of iodine and thiol-blocking reagents with human complement components C2 and factor B. Purification and N-terminal amino acid sequence of a peptide from C2a containing a free thiol group. Biochem J. 1983 Jul 1;213(1):201–209. doi: 10.1042/bj2130201. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Polley M. J., Müller-Eberhard H. J. The second component of human complement: its isolation, fragmentation by C'1 esterase, and incorporation into C'3 convertase. J Exp Med. 1968 Sep 1;128(3):533–551. doi: 10.1084/jem.128.3.533. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Scott D. M., Amos N., Bartolotti S. R. The role of carbohydrate in the structure and function of nephritic factor. Clin Exp Immunol. 1981 Oct;46(1):120–129. [PMC free article] [PubMed] [Google Scholar]
  21. Sobel A. T., Cooper N. R., Schreiber R. D. Activation of the classical complement pathway by nephritic factor bound to the alternative pathway C3/C5 convertase. J Immunol. 1979 Jan;122(1):34–38. [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES